81 related articles for article (PubMed ID: 48596)
1. [Method of preparation of erythrocytic diagnostic agents for detection of antitoxic and antibacterial antibodies in El Tor cholera].
Tsybin BP; Taran IF
Lab Delo; 1975; (3):170-2. PubMed ID: 48596
[No Abstract] [Full Text] [Related]
2. [Methodical recommmendations for conduction of the hemagglutination test with erythrocytic cholera enterotoxic diagnostic agent (ECEDA)].
Lab Delo; 1976; (4):242-. PubMed ID: 66381
[No Abstract] [Full Text] [Related]
3. Serological studies in cholera infection in Calcutta (1966-67).
Deb BC; Ganguly R; Sinho R; Ghosh AK; Succar BK; Abou-Gareeb AH; Ozawa A; Shrivastava DL; Burrows W
Indian J Med Res; 1973 Feb; 61(2):169-78. PubMed ID: 4758991
[No Abstract] [Full Text] [Related]
4. Immunity of cholera in man: relative role of antibacterial versus antitoxic immunity.
Levine MM; Nalin DR; Craig JP; Hoover D; Bergquist EJ; Waterman D; Holley HP; Hornick RB; Pierce NP; Libonati JP
Trans R Soc Trop Med Hyg; 1979; 73(1):3-9. PubMed ID: 442179
[TBL] [Abstract][Full Text] [Related]
5. [The use of immunoenzyme analysis and the vibriocidal antibody reaction in the serological examination of persons who have had cholera and of those in contact with them].
Mareev VI; Moskvitina EA; Gritsenko AN; Ivanova LV; Efanova EA; Nepomniashchaia NB; Dranov IIu; Boldyr' LA; Griseva LN
Zh Mikrobiol Epidemiol Immunobiol; 1991 Feb; (2):34-6. PubMed ID: 1867031
[TBL] [Abstract][Full Text] [Related]
6. [Detection of agglutinins and bacteriolysins in the blood serum of El Tor cholera patients and Vibrio carriers].
Stogova AG; Semiotrochev VL; Zheglova DV
Lab Delo; 1970; 10():594-5. PubMed ID: 4099560
[No Abstract] [Full Text] [Related]
7. Protection afforded by anti-hemolysin against V. cholerae El Tor infection in experimental cholera.
Chaicumpa W; Samrejrongroj P; Atthasishtha N
Southeast Asian J Trop Med Public Health; 1980 Jun; 11(2):294-301. PubMed ID: 7434081
[TBL] [Abstract][Full Text] [Related]
8. A serological survey for cholera antibodies in the population of Jerusalem and surroundings.
Gerichter CB; Sechter I; Cohen J; Davies AM
Isr J Med Sci; 1973 Aug; 9(8):980-5. PubMed ID: 4753851
[No Abstract] [Full Text] [Related]
9. [Utilization of serological methods in the retrospective diagnosis of cholera and in detecting vibrion carriers].
Bunin KV; Firsanov VI; Kravtsov EG; Nechaeva IP; Efimov DD
Zh Mikrobiol Epidemiol Immunobiol; 1975 Oct; (10):98-101. PubMed ID: 1210898
[TBL] [Abstract][Full Text] [Related]
10. [Seroepidemiological survey of El Tor cholera in an endemic region of Algeria].
Bendib A; Nora M; Mahrouf H; Saib M; el Abassi K; Dodin A
Bull Soc Pathol Exot; 1994; 87(3):143-7. PubMed ID: 7827512
[TBL] [Abstract][Full Text] [Related]
11. Antitoxic immunity to cholera in dogs immunized orally with cholera toxin.
Pierce NF; Cray WC; Engel PF
Infect Immun; 1980 Feb; 27(2):632-7. PubMed ID: 7380543
[TBL] [Abstract][Full Text] [Related]
12. [The choice of optimal sensitizing dose of the antigen in the preparation of cholera erythrocytic diagnostic agent, with consideration to the avidity of antibodies under study].
Bunin KV; Firsanov VI; Parfenova NN; Krartsov EG; Efimor DD
Zh Mikrobiol Epidemiol Immunobiol; 1978 Jun; (6):89-92. PubMed ID: 676601
[TBL] [Abstract][Full Text] [Related]
13. Cell-bound haemagglutinin (CHA) of V. cholerae 01 as protective antigen.
Chaicumpa W; Boonthum A; Kalumbaheti T; Tapchaisri P
Southeast Asian J Trop Med Public Health; 1984 Sep; 15(3):407-13. PubMed ID: 6523176
[TBL] [Abstract][Full Text] [Related]
14. [Determination of Vibrio antibody titers during anti-cholera vaccination].
Dirimci OT; Cinar V
Turk Hij Tecr Biyol Derg (1961); 1973; 33(2-3):118-28. PubMed ID: 4807572
[No Abstract] [Full Text] [Related]
15. Breast milk reduces the risk of illness in children of mothers with cholera: observations from an epidemic of cholera in Guinea-Bissau.
Qureshi K; Mølbak K; Sandström A; Kofoed PE; Rodrigues A; Dias F; Aaby P; Svennerholm AM
Pediatr Infect Dis J; 2006 Dec; 25(12):1163-6. PubMed ID: 17133163
[TBL] [Abstract][Full Text] [Related]
16. In vitro production of toxin-coregulated pili by Vibrio cholerae El Tor.
Voss E; Attridge SR
Microb Pathog; 1993 Oct; 15(4):255-68. PubMed ID: 7906005
[TBL] [Abstract][Full Text] [Related]
17. The study of intestinal immunity against V. cholerae: purification of V. cholerae El Tor haemagglutinin and the protective role of its antibody in experimental cholera.
Chaicumpa W; Atthasishtha N
Southeast Asian J Trop Med Public Health; 1979 Mar; 10(1):73-80. PubMed ID: 483020
[TBL] [Abstract][Full Text] [Related]
18. Immunisation against cholera with a Ty21a-cholera hybrid.
La Brooy JT; Forrest B; Bartholomeusz C
Ann Sclavo Collana Monogr; 1986; 3(1-2):143-7. PubMed ID: 3426872
[No Abstract] [Full Text] [Related]
19. Impact of epidemic cholera in a previously uninfected island population: evaluation of a new seroepidemiologic method.
Harris JR; Holmberg SD; Parker RD; Kay DE; Barrett TJ; Young CR; Levine MM; Blake PA
Am J Epidemiol; 1986 Mar; 123(3):424-30. PubMed ID: 3946388
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the cholera spot test: a chromatographic immunoassay for the rapid detection of cholera antigen.
Rohani MY; Hasnidah D; Ong KH
Malays J Pathol; 1998 Jun; 20(1):31-3. PubMed ID: 10879261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
